carbamates has been researched along with Dementia, Vascular in 13 studies
Dementia, Vascular: An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recent data indicate that patients with vascular dementia (VaD) show a cholinergic deficit." | 2.71 | Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study. ( Antonello, RM; Bava, A; Cazzato, G; Griggio, S; Moretti, R; Torre, P; Ukmar, M, 2004) |
| "Efficacy measures included the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog), the Clinician's Interview Based Impression of Change (CIBIC-Plus), the Progressive Deterioration Scale (PDS), the Global Deterioration Scale (GDS), and the Mini-Mental State Examination (MMSE)." | 2.69 | An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors. ( Anand, R; Hartman, R; Kumar, V; Messina, J; Veach, J, 2000) |
| "Patients with vascular dementia (VaD) show cholinergic deficits that may result in characteristic clinical syndromes for different subtypes of the condition." | 2.42 | Rivastigmine in vascular dementia. ( Antonello, RM; Bava, A; Cazzato, G; Moretti, R; Torre, P, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moretti, R | 4 |
| Torre, P | 4 |
| Antonello, RM | 4 |
| Cazzato, G | 4 |
| Bava, A | 3 |
| Alagiakrishnan, K | 1 |
| Sclater, A | 1 |
| Robertson, D | 1 |
| Bonelli, RM | 1 |
| Fuchsberger, T | 1 |
| Möller, HJ | 1 |
| Hampel, H | 1 |
| Baezner, H | 1 |
| Daffertshofer, M | 1 |
| Lojkowska, W | 1 |
| Ryglewicz, D | 1 |
| Jedrzejczak, T | 1 |
| Minc, S | 1 |
| Jakubowska, T | 1 |
| Jarosz, H | 1 |
| Bochynska, A | 1 |
| Bastos Leite, AJ | 1 |
| van Straaten, EC | 1 |
| Scheltens, P | 1 |
| Lycklama, G | 1 |
| Barkhof, F | 1 |
| Erkinjuntti, T | 1 |
| Román, G | 1 |
| Gauthier, S | 1 |
| Feldman, H | 1 |
| Rockwood, K | 1 |
| Griggio, S | 1 |
| Ukmar, M | 1 |
| Tayebati, SK | 1 |
| Di Tullio, MA | 1 |
| Amenta, F | 1 |
| Kumar, V | 1 |
| Anand, R | 1 |
| Messina, J | 1 |
| Hartman, R | 1 |
| Veach, J | 1 |
3 reviews available for carbamates and Dementia, Vascular
| Article | Year |
|---|---|
[Current therapy of patients with dementia].
Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Controlled Cli | 2003 |
[Subcortical vascular encephalopathy].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amantadine; Brain; Carbamates; Clinical Trials as Topic; | 2003 |
Rivastigmine in vascular dementia.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Clinical Trials | 2004 |
5 trials available for carbamates and Dementia, Vascular
| Article | Year |
|---|---|
Rivastigmine in subcortical vascular dementia: an open 22-month study.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Behavior; Carbamates; Caregivers; Cholinesteras | 2002 |
The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia.
Topics: Acetylcholine; Aged; Alzheimer Disease; Auditory Perception; Carbamates; Cerebrovascular Circulation | 2003 |
Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study.
Topics: Aged; Aged, 80 and over; Aspirin; Carbamates; Cholinesterase Inhibitors; Cognition Disorders; Dement | 2004 |
An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Dementia, Vascula | 2000 |
Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up.
Topics: Aged; Carbamates; Dementia, Vascular; Female; Follow-Up Studies; Humans; Male; Neuroprotective Agent | 2001 |
5 other studies available for carbamates and Dementia, Vascular
| Article | Year |
|---|---|
Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman.
Topics: Aged; Aggression; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Dementia, Vascular; Fema | 2003 |
Editorial comment--How to treat vascular dementia?
Topics: Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Donepezil; Gala | 2003 |
Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging.
Topics: Aged; Aged, 80 and over; Carbamates; Clinical Trials, Phase III as Topic; Dementia, Vascular; Humans | 2004 |
Emerging therapies for vascular dementia and vascular cognitive impairment.
Topics: Carbamates; Cardiovascular Diseases; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition | 2004 |
Effect of treatment with the cholinesterase inhibitor rivastigmine on vesicular acetylcholine transporter and choline acetyltransferase in rat brain.
Topics: Animals; Blood Pressure; Brain; Brain Chemistry; Carbamates; Choline O-Acetyltransferase; Cholineste | 2004 |